AKTIV-DRY

Address

2100 Central Ave., Suite 109
Boulder, CO, 80301-

Information

DUNS: 136952087
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Thermostable Sublingual Measles Vaccine Dry Wafers

    Amount: $149,998.00

    "Measles is a highly contagious, human disease that is spread by the respiratory route, and, in the developing world, remains a leading cause of death due to vaccine-preventable infectious diseases in ...

    SBIRPhase I2013Department of Health and Human Services
  2. A new, rapidly dissolving and thermally stable dry powder Hepatitis-B vaccine

    Amount: $939,918.00

    DESCRIPTION (provided by applicant): The overarching goal of this project is to move a new, dry powder formulation of Hepatitis-B vaccine on its path to commercialization. In the Phase I SBIR we teste ...

    SBIRPhase II2012Department of Health and Human Services
  3. Aktiv-Neb: A Dry Powder Inhaler for Anti-RSV siRNA Microparticles

    Amount: $99,990.00

    DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project aims to develop a novel dry powder inhalation system, Aktiv-NebTM, for delivering antiviral drug (siRNAs) p ...

    SBIRPhase I2008Department of Health and Human Services
  4. Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an

    Amount: $823,623.00

    DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry po ...

    SBIRPhase II2008Department of Health and Human Services
  5. Product Formulation and Process Design for Commercial Production of Soluable Phytosterols

    Amount: $296,000.00

    Commercially available products rich in phytosterol may now be used to cut serum low-density lipoprotein by as much as 14 percent. Unfortunately, phytosterols are poorly soluble and therefore present ...

    SBIRPhase II2006Department of Agriculture
  6. Development of a Micronized Needle-Free Nicotine Vaccine for Smoking Cessation an

    Amount: $99,989.00

    DESCRIPTION (provided by applicant): Aktiv-Dry LLC, in collaboration with Nabi Biopharmaceuticals, proposes to develop and evaluate in animal models the needle-free respiratory delivery of fine dry po ...

    SBIRPhase I2006Department of Health and Human Services
  7. A New Process for Producing Phytosterol and Lycopene Nano- and Micro-Particles

    Amount: $79,985.00

    Phytosterols and lycopene are neutraceuticals that are known antioxidants and cancer inhibitors. Unfortunately, they do not dissolve readily in body fluids and therefore present unique problems concer ...

    SBIRPhase I2004Department of Agriculture
  8. Inhalable IgG Synthesis For Influenza Immunoprophylaxis

    Amount: $99,600.00

    DESCRIPTION (provided by applicant): This Phase I SBIR proposal is the first step in the development of inhalable IgG microparticles for immunoprophylaxis against Influenza A, a category C Priority P ...

    SBIRPhase I2004Department of Health and Human Services
  9. Stability and functionality of the Immunoject single-dose, auto-reconstitution de

    Amount: $200,000.00

    DESCRIPTION (provided by applicant): Assuring the success of mass campaigns against bioterrorist or naturally occurring pathogens requires that vaccines, therapeutics, and other products are stored an ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government